… Competing interests: I have read the journal’s policy and the authors of this manuscript have
the … Due to the nature of the interventions considered in this review, the study’s participants …

… (referred as bolus expansion in Moyer’s article). Eclipse looks from each … ): S m e a r i n g
margin = ( IM + S M ) 2 + [ 0.03 × ( d i s t a l C T V d e p t h + c o m p e n s a t o r t h i c k n e s s ) ] …

… There were varying treatment doses, as indicated by each patient’s specific history with some
patients undergoing reirradiation. Doses ranged from 36–45 Gy (1.5–2.5 Gy/fx). The DVHs …

Acquired drug resistance to anticancer targeted therapies remains an unsolved clinical
problem. Although many drivers of acquired drug resistance have been identified 1 , 2 , 3 – 4 , …

… IC 50 shift corresponds to the ratio of IC 50 s calculated in the presence or absence of
ARS1620. Primary hits were identified using a 2-fold IC 50 shift. We have previously shown that …

… used to treat Ewing’s sarcoma, consisting of … s most recent PET/CT scan was fused to the
simulation CT images to assist in delineation of the target areas for focal boosting. The patient’s …

Evolved resistance to tyrosine kinase inhibitor (TKI)-targeted therapies remains a major clinical
challenge. In epidermal growth factor receptor (EGFR) mutant non-small-cell lung cancer …

The purpose of this work is to estimate the uncertainty in the manual contouring of normal
anatomical structures. The heart, esophagus, and spinal cord were contoured manually on six …

Introduction We investigated safety, efficacy, and recurrence after postoperative
hemithoracic intensity-modulated radiation therapy (IMRT) in patients with malignant pleural …

Defining the molecular basis for MCL1 versus BCL-xL dependency will be essential for
effective prioritization of BH3 mimetic combination therapies in the clinic. We discover a novel …